Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein strains target distinct brain regions and cell types
Angus Lau, Raphaella W. L. So, Heather H. C. Lau, et al.
Nature Neuroscience (2019) Vol. 23, Iss. 1, pp. 21-31
Open Access | Times Cited: 244

Showing 26-50 of 244 citing articles:

Monitoring α-synuclein aggregation
Juan Estaun-Panzano, Marie-Laure Arotçarena, Erwan Bézard
Neurobiology of Disease (2022) Vol. 176, pp. 105966-105966
Open Access | Times Cited: 48
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 613-640
Open Access | Times Cited: 46
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 45
CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology
Shay Herman, Ruth Djaldetti, Brit Mollenhauer, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 209-224
Open Access | Times Cited: 42
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease
Jia Lu, Chenfei Wang, Xin R. Cheng, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Molecular mechanisms of amyloid formation in living systems
Tessa Sinnige
Chemical Science (2022) Vol. 13, Iss. 24, pp. 7080-7097
Open Access | Times Cited: 41
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 936-948
Open Access | Times Cited: 39
Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology
Youqi Tao, Yunpeng Sun, Shiran Lv, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
Samuel Peña‐Díaz, Javier García‐Pardo, Salvador Ventura
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 839-839
Open Access | Times Cited: 27
Astrocytes in selective vulnerability to neurodegenerative disease
Till S. Zimmer, Adam L. Orr, Anna G. Orr
Trends in Neurosciences (2024) Vol. 47, Iss. 4, pp. 289-302
Open Access | Times Cited: 14
Upregulated pexophagy limits the capacity of selective autophagy
Kyla Germain, Raphaella W. L. So, Laura F. DiGiovanni, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives
Diana F. Lázaro, Virginia M.‐Y. Lee
Neuron (2024)
Closed Access | Times Cited: 8
Positron emission tomography tracers for synucleinopathies
Jie Xiang, Zhentao Zhang, Shengxi Wu, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
Stefan Bräuer, Iñaki Schniewind, Elisabeth Dinter, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The role of natural killer cells in Parkinson’s disease
Rachael H. Earls, Jae‐Kyung Lee
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1517-1525
Open Access | Times Cited: 68
Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs
Amulya Nidhi Shrivastava, Luc Bousset, Marianne Renner, et al.
Biophysical Journal (2020) Vol. 118, Iss. 6, pp. 1301-1320
Open Access | Times Cited: 66
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 391-391
Open Access | Times Cited: 55
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
Genjiro Suzuki, Sei Imura, Masato Hosokawa, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 55
Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease
Yang Li, Chen Yang, Shilin Wang, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 562-573
Closed Access | Times Cited: 53
Amyloid-β oligomerization monitored by single-molecule stepwise photobleaching
Lara Dresser, Patrick Hunter, Fatima Yendybayeva, et al.
Methods (2020) Vol. 193, pp. 80-95
Open Access | Times Cited: 51
Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy
Fillipe M. de Araújo, Lorena Cuenca‐Bermejo, Emiliano Fernández‐Villalba, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 5, pp. 1283-1300
Closed Access | Times Cited: 51
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
Shady Rahayel, Bratislav Mišić, Ying‐Qiu Zheng, et al.
Brain (2021) Vol. 145, Iss. 5, pp. 1743-1756
Open Access | Times Cited: 48
Neurons and Glia Interplay in α-Synucleinopathies
Panagiota Mavroeidi, Maria Xilouri
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4994-4994
Open Access | Times Cited: 43
Uncovering the universality of self-replication in protein aggregation and its link to disease
Georg Meisl, Catherine K. Xu, Jonathan D. Taylor, et al.
Science Advances (2022) Vol. 8, Iss. 32
Open Access | Times Cited: 37
Parkinson's Disease: Risk Factor Modification and Prevention
Suraj Rajan, Bonnie Kaas
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 626-638
Closed Access | Times Cited: 35

Scroll to top